Integriderm, of Huntsville, Alabama, together with its partner Invitrogen, has launched PharmArray, a new microarray with genes specifically selected for toxicology and pharmacology research on ADME (absorption, distribution, metabolism, and excretion). The nylon-based array, which is designed to be reused up to five times, contains 4,400 human cDNAs that relate to hepatic, renal, neural, and gastrointestinal function. The genes were chosen using IntegridermÃs patent pending gene selection method, which zeroes in on genes likely to be involved in a particular function or disease.
The arrays, which can be ordered now and will ship in mid-July, cost $1,580 per filter if a customer buys ten or more. The company also offers volume discounts. Integriderm also offers an array service for PharmArray and for DermArray, a chip with genes involved in skin disease. Arrays and service can be ordered through the companyÃs website, www.integriderm.com.
Â
Genomic Solutions of Ann Arbor, Mich. will provide its GeneTAC HybStation and its new GeneTAC UC-4 Microarray Analyzer to the Marine Biological Laboratory in Woods Hole, Mass., from July 30 through August 18. The instruments will be used for microarray experiments in a course entitled "Molecular Biology of Aging," which comprises part of the labÃs summer education and research program. Company representatives will also perform workshops and demonstrations on campus during this time. The HybStation allows for hybridization of up to 12 microarrays at a time, while the UC-4 can scan four microarrays at a time. The HybStation is currently available, and the UC-4 will be launched during the third quarter, according to the company.